Skip to content

Effectiveness of MIST (minimally invasive surfactant therapy) under bronchoscopy in treating neonatal respiratory distress syndrome

Effectiveness of MIST (minimally invasive surfactant therapy) under bronchoscopy in treating neonatal respiratory distress syndrome - Minimally invasive surfactant therapy under bronchoscopy in treating neonatal respiratory distress syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021785
Enrollment
30
Registered
2016-04-05
Start date
2016-01-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal respiratory distress syndrome

Interventions

Place the infant inside the incubator and start nasal continuous positive airway pressure. Displace one of the prongs, and insert the bronchoscope from the open nostril. Place the tip of the bronchosc

Sponsors

Tokyo Women's Medical University Adachi Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients fulfilling all of the following criteria will be included 1. Patients born at Tokyo Women's Medical University Medical Center East, and admitted to the NICU 2. Patients diagnosed with respiratory distress syndrome 3. Informed consent obtained from parents 4. Patients thought to be appropriate for the study by the attending physician

Exclusion criteria

Exclusion criteria: Patients fulfilling any of the following criteria will be excluded 1. Patients with severe birth asphyxia 2. Patients with multiple malformation syndrome, or other suspected underlying diseases 3. Patients needing vasoactive drugs 4. Patients with tendency to bleed 5. Patients with congenital infections 6. Patients thought to be inappropriate for the study by the supervising physician

Design outcomes

Primary

MeasureTime frame
Short term prognosis of respiration in patients treated with bronchoscopic MIST. Short term prognosis of respiration includes the following 1. Days under mechanical ventilation 2. Days under supplemental oxygen 3. Incidence of airway diseases 4. Need for endotracheal intubation or additional surfactant

Secondary

MeasureTime frame
1. Morbidity of diseases often seen in premature infants(intraventricular hemorrhage, pneumothorax, patent ductus arteriosus, bronchopulmonary dysplasia, sepsis, necrotizing enterocolitis) 2. Length of hospitalization, mortality rate

Countries

Japan

Contacts

Public ContactMasanori Wasa

Tokyo Women's Medical University Adachi Medical Center Neonatology

wasa.masanori@twmu.ac.jp03-3857-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026